Syntropic Medical
Syntropic’s treatment for Major Depressive Disorder is a brain stimulation device based on a light stimulation protocol that was discovered by the Siegert Group at ISTA
Total raised
€1.1M
€1,100,000
Funding rounds
3
Investors
4
distinct backers
Active since
2024-04
latest 2025-12
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood33
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood11
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▼ Young (<3y)
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-05 | Other | — | better ventures | View deal → |
| 2024-07-23 | Other | €1.1M | Austrian Research Promotion Agency (FFG),xista science ventures | View deal → |
| 2024-04-04 | Other | — | AWS,xista science ventures | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce